Showing results (21-30 of 181) with videos related to
Sort By:
Pageof 19
Seminars in Radiation Oncology|June 10, 2022
Harnessing the DNA Repair Pathway in Breast Cancer: Germline Mutations/Polymorphisms in Breast RadiationMichael D Green, Randall Brenneman, Simon N Powell, et al.NAR Cancer|December 25, 2025
Contrasting roles of APE1 and APE2 in genome maintenance, cancer development, and therapeutic targetingAman Sharma, Helen E Grimsley, Katharine Courtemanche, et al.International Journal of Radiation Oncology, Biology, Physics|May 15, 2002
Dose-escalated total body irradiation and autologous stem cell transplantation for refractory hematologic malignancySteven L McAfee, Simon N Powell, Christine Colby, et al.The Journal of Biological Chemistry|April 17, 2004
DNA damage induces p53-dependent BRCA1 nuclear exportZhihui Feng, Lisa Kachnic, Junran Zhang, et al.Nucleic Acids Research|April 16, 2013
Development of an assay to measure mutagenic non-homologous end-joining repair activity in mammalian cellsRanjit S Bindra, Alexander G Goglia, Maria Jasin, et al.Oncogene|October 19, 2004
The interaction of p53 with replication protein A mediates suppression of homologous recombinationLarisa Y Romanova, Henning Willers, Mikhail V Blagosklonny, et al.Cancer Research|October 7, 2004
ATR affecting cell radiosensitivity is dependent on homologous recombination repair but independent of nonhomologous end joiningHongyan Wang, Huichen Wang, Simon N Powell, et al.DNA Repair|April 4, 2015
BRCA1 and BRCA2 protect against oxidative DNA damage converted into double-strand breaks during DNA replicationRam Fridlich, Devi Annamalai, Rohini Roy, et al.Nature Communications|August 19, 2018
The therapeutic significance of mutational signatures from DNA repair deficiency in cancerJennifer Ma, Jeremy Setton, Nancy Y Lee, et al.Breast Cancer Research and Treatment|January 29, 2022
Examining the prevalence of homologous recombination repair defects in ER+ breast cancersGrace M Moore, Simon N Powell, Daniel S Higginson, et al.Pageof 19